Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 14/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.61 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nafoxidine SCHEMBL10563464 | 1.00 | EBP (1.00) | EBPSIGMAR1ESR1ESR2LTA4H | |
| Nafoxidine SCHEMBL29494604 | 1.00 | EBP (1.00) | EBPSIGMAR1ESR1ESR2LTA4H | |
| Nafoxidine SCHEMBL115778 | 0.99 | EBP (0.98) | EBPSIGMAR1ESR1ESR2LTA4H | |
| Nafoxidine SCHEMBL8430193 | 0.99 | EBP (0.98) | EBPSIGMAR1ESR1ESR2LTA4H | |
| Nafoxidine SCHEMBL29562423 | 0.99 | EBP (0.98) | EBPSIGMAR1ESR1ESR2LTA4H | |
| SCHEMBL8015672 | 0.94 | EBP (0.88) | EBPSIGMAR1ESR1ESR2LTA4H | |
| SCHEMBL2811903 | 0.94 | EBP (0.88) | EBPSIGMAR1ESR1ESR2LTA4H | |
| SCHEMBL2811811 | 0.93 | EBP (0.86) | EBPSIGMAR1ESR1ESR2LTA4H | |
| SCHEMBL13350303 | 0.93 | EBP (0.86) | EBPSIGMAR1ESR1ESR2LTA4H | |
| SCHEMBL2817373 | 0.93 | EBP (0.86) | EBPSIGMAR1ESR1ESR2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5407 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346800-A1 | REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR | ENDORECHERCHE, INC. (CA) | 2023-11-02 | — | — | US | claimed |
| US-20230338355-A1 | NK ANTAGONISTS FOR CONTRACEPTION | ACER THERAPEUTICS INC. | 2023-10-26 | — | — | US | claimed |
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| US-11690852-B2 | Reduction of the incidence or recurrence of breast cancer in postmenopausal women treated with intravaginal sex steroid precursor | ENDORECHERCHE. INC. | 2023-07-04 | — | — | US | claimed |
| EP-4157242-A1 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | Galera Labs, LLC (US) | 2023-04-05 | — | — | EP | claimed |
| WO-2023012353-A1 | COMPOUNDS FOR USE IN THE THERAPEUTIC TREATMENT OF BATTEN DISEASE | FONDAZIONE TELETHON (IT) | 2023-02-09 | — | — | WO | claimed |
| US-20220313703-A1 | REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR | ENDORECHERCHE, INC. (CA) | 2022-10-06 | — | — | US | claimed |
| US-20220249413-A1 | SWELL 1 MODULATORS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, IMMUNE DEFICIENCIES, MALE INFERTILITY AND VASCULAR DISEASES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2022-08-11 | — | — | US | claimed |
| CN-114514021-A | SWELL1 modulators for the treatment of non-alcoholic fatty liver disease, immunodeficiency, male infertility, and vascular disease | 爱荷华大学研究基金会 | 2022-05-17 | — | — | CN | claimed |
| EP-3982944-A1 | SWELL 1 MODULATORS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, IMMUNE DEFICIENCIES, MALE INFERTILITY AND VASCULAR DISEASES | University of Iowa Research Foundation (US) | 2022-04-20 | — | — | EP | claimed |
| WO-1995026720-A1 | PERMANENTLY IONIC DERIVATIVES OF STEROID HORMONES AND THEIR ANTAGONISTS | PHARMOS CORPORATION (US) | 1995-10-12 | — | — | WO | claimed |
| WO-1995011013-A2 | COMBINATION OF PROGESTERONE ANTAGONISTS AND ANTI-OESTROGENS WITH PARTIAL AGONISTIC ACTION FOR USE IN HORMONE-REPLACEMENT THERAPY FOR PERI- AND POST-MENOPAUSAL WOMEN | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-04-27 | — | — | WO | claimed |
| WO-1995005828-A1 | PROGESTERONE-ANTAGONISTIC AND ANTI-OESTROGEN COMPOUNDS FOR THE THERAPY OF LEIOMYOMATA UTERI | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-03-02 | — | — | WO | claimed |
| EP-0246654-B1 | Use of a sulfated polysaccharide | DAIICHI SEIYAKU CO (JP) | 1993-11-10 | — | — | EP | claimed |
| EP-0178862-B1 | ANTIESTROGEN THERAPY FOR SYMPTOMS OF ESTROGEN DEFICIENCY | BCM Technologies, INC. (US) | 1993-08-04 | — | — | EP | claimed |
| US-4900815-A | Sulfated polysaccharide DS4152 | DAIICHI SEIYAKU CO., LTD. (JP) | 1990-02-13 | — | — | US | claimed |
| US-4894373-A | CLOMIPHEN, ISOMERS AND SALTS | BCM TECHNOLOGIES, INC. (US) | 1990-01-16 | — | — | US | claimed |
| US-4729999-A | MENOPAUSE, SIDE EFFECT PREVENTION | BCM TECHNOLOGIES (US) | 1988-03-08 | — | — | US | claimed |
| EP-0246654-A2 | Use of a sulfated polysaccharide | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1987-11-25 | — | — | EP | claimed |
| EP-0178862-A2 | Antiestrogen therapy for symptoms of estrogen deficiency | BCM Technologies, INC. (US) | 1986-04-23 | — | — | EP | claimed |